|
Endometriosis of ovary
|
0.010 |
Biomarker
|
disease |
BEFREE |
These cytokines, periostin, and TCF21 colocalized in the stroma of OE and DIE. siRNA against human TCF21 gene suppressed periostin expression.
|
31610174 |
2020 |
|
Stress induced hyperglycaemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Following bariatric surgery, the impact of stress induced hyperglycemia is primarily on POD 0 in non-diabetics whereas the effect extends into POD 1 for diabetics.
|
31757437 |
2020 |
|
SMITH-MCCORT DYSPLASIA 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Objective:</b> To better understand how TCF21 affects SMC phenotype, we sought to investigate the possible mechanisms by which it regulates the lineage determining myocardin (MYOCD)-serum response factor (SRF) pathway.
|
31815603 |
2020 |
|
Delirium
|
0.010 |
Biomarker
|
disease |
BEFREE |
During postoperative POD 1 to POD 7, the incidence of delirium is lower in the DEX group than that in the control group.
|
30948695 |
2019 |
|
Hyponatremia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In binary logistic regression analysis, age >60 years (odds ratio [OR], 2.22; 95% confidence interval [CI], 1.16-4.26; P = 0.017), the nadir sodium concentration on POD 1-2 (OR, 0.88; 95% CI, 0.77-0.99; P = 0.034), and operation time (OR, 1.01; 95% CI, 1.00-1.02; P = 0.018) were independent risk factors for delayed hyponatremia after endoscopic transsphenoidal pituitary surgery.
|
30465961 |
2019 |
|
Kidney Failure, Acute
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
LRV harvest was an independent risk factor for AKI at POD1 and POD3, but not thereafter.
|
30322713 |
2019 |
|
Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
|
31312357 |
2019 |
|
Ovarian Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the present study, we define clinical stratification of HGSC tumors through the establishment of standard operating procedures for immunohistochemistry and histochemistry based detection of a panel of biomarkers including TCF21, E-cadherin, PARP1, Slug, AnnexinA2, and hyaluronan.
|
30857227 |
2019 |
|
Respiratory Distress Syndrome, Adult
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Serum CC16 levels on POD1 increased significantly from the pretransplant state in the ARDS group but not in the non-ARDS group.
|
31111072 |
2019 |
|
Septicemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SOFA scores at POD 1-7 can effectively predict the incidence of sepsis and 30-day mortality in liver transplant patients on the basis of CRP and PCT.
|
30721450 |
2019 |
|
Secondary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further, Kisspeptin 1 (KISS1) was identified as a TCF21 downstream effector responsible for miR-3648-mediated BC invasion and lung metastasis.
|
31071528 |
2019 |
|
Malnutrition
|
0.010 |
Biomarker
|
disease |
BEFREE |
The hydration index on POD1 was significantly higher in patients who experienced major complications than in uncomplicated patients (P=0.020 and P=0.025 for CDC and CCI, respectively).At a linear regression model, age (β=0.14, P=0.035), sex female (β=0.40, P<0.001), BMI (β=0.30, P<0.001), and malnutrition (β=0.14, P=0.037) were independent predictors of postoperative ECW.
|
31592889 |
2019 |
|
Cholangiocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
<b>NEW & NOTEWORTHY</b> Transcription factor 21 (TCF21) is downregulated in cholangiocarcinoma (CCA) tissues or cells.
|
30920845 |
2019 |
|
Congenital contractural arachnodactyly
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TCF21 was significantly downregulated in CCA tissues or cell lines.
|
30920845 |
2019 |
|
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
Tcf21 was also examined for its effects by adeno-associated viruses serotype 6 (AAV6)-mediated Tcf21 gene transfer into cultured activated HSCs and mice with carbon tetrachloride- or methionine-choline deficient diet-induced liver fibrosis.
|
31549421 |
2019 |
|
Sepsis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SOFA scores at POD 1-7 can effectively predict the incidence of sepsis and 30-day mortality in liver transplant patients on the basis of CRP and PCT.
|
30721450 |
2019 |
|
Acute retention of urine
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Comparison of urinary catheter removal on POD 1 versus POD 3 demonstrated no significant difference in rate of urinary retention (RR 1.36, 95%CI 0.83-2.21, P = 0.22); however, compared to POD 5, rates of AUR were significantly higher (RR 2.58, 95%CI 1.51-4.40, P = 0.0005).
|
31707560 |
2019 |
|
Adrenal cortical hypofunction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hypocortisolemia on POD1 (serum cortisol < 5 μg/dl) prompted a 7 am cortisol level measurement on POD 2 (POD2).
|
30835697 |
2019 |
|
Postoperative Nausea and Vomiting
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Children receiving acupuncture plus antiemetic therapy had less risk of developing nausea during phase I and II recovery, but there was no difference in PONV on POD 1.
|
30397904 |
2019 |
|
Pelvic Organ Prolapse
|
0.010 |
Biomarker
|
disease |
BEFREE |
To evaluate if discharge on the day of surgery (POD0) is associated with increased 30-day unanticipated healthcare encounters after major pelvic organ prolapse (POP) surgery compared to discharge on or after post-operative day 1 (POD1).
|
31733206 |
2019 |
|
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
AKI occurred more frequently in the LRV group at POD1 (5/17 vs. 4/59, p = 0.023) and POD3 (5/17 vs. 3/59, p = 0012), with no difference in CKD between groups (2/11 vs. 5/33 at 3 months, p = 0.99).
|
30322713 |
2019 |
|
Childhood Myelodysplastic Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
|
31312357 |
2019 |
|
Mechanical Allodynia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Administration of adenovirus-shRNA-JAK2 on POD 1 reduced mechanical allodynia and downstream STAT activation.
|
31454541 |
2019 |
|
MYELODYSPLASTIC SYNDROME
|
0.010 |
Biomarker
|
group |
BEFREE |
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
|
31312357 |
2019 |
|
Adult Myelodysplastic Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
|
31312357 |
2019 |